Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Classical hematology 1

Conditions

Pain, Intractable 1Neoplasms 1Mucositis 1Leukemia 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 8Whole-Body Irradiation 7fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5fludarabine 4Tacrolimus 4Melphalan 4Busulfan 4Stem Cell Transplantation 2Sirolimus 2nicotinamide-beta-riboside 1methanesulfonic acid 1daratumumab 1X-Rays 1Valganciclovir 1Transplantation 1Therapeutics 1Specimen Handling 1Radiotherapy 1Polymerase Chain Reaction 1Passive Cutaneous Anaphylaxis 1Morphine 1Methotrexate 1Methadone 1Mesna 1Influenza Vaccines 1Hydromorphone 1Honey 1Hematopoietic Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Aplastic × Passive Cutaneous Anaphylaxis × 1 year × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡